These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24909809)

  • 41. Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.
    Allali F; Breban M; Porcher R; Maillefert JF; Dougados M; Roux C
    Ann Rheum Dis; 2003 Apr; 62(4):347-9. PubMed ID: 12634235
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.
    Mazzantini M; Di Munno O; Sinigaglia L; Bianchi G; Rossini M; Mela Q; Del Puente A; Frediani B; Cantatore F; Adami S
    Clin Exp Rheumatol; 2007; 25(5):709-15. PubMed ID: 18078618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study.
    Ruppert K; Cauley J; Lian Y; Zgibor JC; Derby C; Solomon DH
    Osteoporos Int; 2018 Feb; 29(2):347-354. PubMed ID: 29075805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of tumour necrosis factor-α inhibitor on serum level of dickkopf-1 protein and bone morphogenetic protein-7 in ankylosing spondylitis patients with high disease activity.
    Korkosz M; Gąsowski J; Leszczyński P; Pawlak-Buś K; Jeka S; Siedlar M; Grodzicki T
    Scand J Rheumatol; 2014; 43(1):43-8. PubMed ID: 24447112
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low levels of serum uric Acid increase the risk of low bone mineral density in young male patients with ankylosing spondylitis.
    Kang KY; Hong YS; Park SH; Ju JH
    J Rheumatol; 2015 Jun; 42(6):968-74. PubMed ID: 25834199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases.
    Wang DM; Zeng QY; Chen SB; Gong Y; Hou ZD; Xiao ZY
    Clin Exp Rheumatol; 2015; 33(4):465-70. PubMed ID: 25962324
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Tada M; Inui K; Sugioka Y; Mamoto K; Okano T; Koike T
    Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitamin D receptor initiation codon polymorphism, bone density and inflammatory activity of patients with ankylosing spondylitis.
    Obermayer-Pietsch BM; Lange U; Tauber G; Frühauf G; Fahrleitner A; Dobnig H; Hermann J; Aglas F; Teichmann J; Neeck G; Leb G
    Osteoporos Int; 2003 Dec; 14(12):995-1000. PubMed ID: 14530911
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association between bone turnover markers, clinical variables, spinal syndesmophytes and bone mineral density in Mexican patients with ankylosing spondylitis.
    Gamez-Nava JI; de la Cerda-Trujillo LF; Vazquez-Villegas ML; Cons-Molina F; Alcaraz-Lopez MF; Zavaleta-Muñiz SA; Rocha-Muñoz AD; Martinez-Garcia EA; Corona-Sanchez EG; Salazar-Paramo M; Fajardo-Robledo NS; Olivas-Flores EM; Cardona-Muñoz EG; Gonzalez-Lopez L
    Scand J Rheumatol; 2016 Nov; 45(6):480-490. PubMed ID: 27218482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Radiographic progression in patients with ankylosing spondylitis according to tumor necrosis factor blocker exposure: Observation Study of Korean Spondyloarthropathy Registry (OSKAR) data.
    Kim TJ; Shin JH; Kim S; Sung IH; Lee S; Song Y; Kim TH
    Joint Bone Spine; 2016 Oct; 83(5):569-72. PubMed ID: 26948670
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Infliximab improves bone metabolism and bone mineral density in rheumatoid arthritis and ankylosing spondylitis: a prospective 2-year study.
    Dischereit G; Tarner IH; Müller-Ladner U; Lange U
    Clin Rheumatol; 2013 Mar; 32(3):377-81. PubMed ID: 23179009
    [No Abstract]   [Full Text] [Related]  

  • 52. Radiographic texture analysis of densitometer-generated calcaneus images differentiates postmenopausal women with and without fractures.
    Vokes TJ; Giger ML; Chinander MR; Karrison TG; Favus MJ; Dixon LB
    Osteoporos Int; 2006 Oct; 17(10):1472-82. PubMed ID: 16838099
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with the lumbar spine and proximal femur bone mineral density in older men.
    Cauley JA; Fullman RL; Stone KL; Zmuda JM; Bauer DC; Barrett-Connor E; Ensrud K; Lau EM; Orwoll ES;
    Osteoporos Int; 2005 Dec; 16(12):1525-37. PubMed ID: 15889316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis.
    Henderson C; Davis JC
    Nat Clin Pract Rheumatol; 2006 Apr; 2(4):211-8. PubMed ID: 16932687
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK; Huang M; Prasad GV
    J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Change in Trabecular Bone Score (TBS) With Antiresorptive Therapy Does Not Predict Fracture in Women: The Manitoba BMD Cohort.
    Leslie WD; Majumdar SR; Morin SN; Hans D; Lix LM
    J Bone Miner Res; 2017 Mar; 32(3):618-623. PubMed ID: 27933656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis.
    Torres L; Klingberg E; Nurkkala M; Carlsten H; Forsblad-d'Elia H
    Osteoporos Int; 2019 Feb; 30(2):441-449. PubMed ID: 30306221
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Effect of TNF Inhibition on Bone Density and Fracture Risk and of IL17 Inhibition on Radiographic Progression and Bone Density in Patients with Axial Spondyloarthritis: a Systematic Literature Review.
    Ashany D; Stein EM; Goto R; Goodman SM
    Curr Rheumatol Rep; 2019 Mar; 21(5):20. PubMed ID: 30868279
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Short-term effects of extracorporeal shock wave therapy on bone mineral density in postmenopausal osteoporotic patients.
    Shi L; Gao F; Sun W; Wang B; Guo W; Cheng L; Li Z; Wang W
    Osteoporos Int; 2017 Oct; 28(10):2945-2953. PubMed ID: 28685283
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of three years of TNFα blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study.
    Arends S; Spoorenberg A; Houtman PM; Leijsma MK; Bos R; Kallenberg CG; Groen H; Brouwer E; van der Veer E
    Arthritis Res Ther; 2012 Apr; 14(2):R98. PubMed ID: 22546520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.